Long-term Consequences of COVID-19: Chemosensory Disorders.
Bo LiaoYi-Ke DengMing ZengZheng LiuPublished in: Current allergy and asthma reports (2022)
Although the prevalence of OD and GD has declined continuously after acute COVID-19, a considerable number of patients had persistent chemosensory disorders 3 months to 2 years after symptom onset. Female gender, initial severity of dysfunction, nasal congestion, emotional distress and depression, and SARS-CoV-2 variants have been identified as risk factors for persistent OD and GD in long COVID-19. The pathogenesis of OD and GD in long COVID-19 remains unknown, but may be analogous to the persistent OD and GD post common respiratory viral infection. Corticosteroids and olfactory training might be a potential choice regarding the treatment of lasting OD and GD after SARS-CoV-2 infection; however, more studies are needed to prove it. OD and GD are common long-term consequences of COVID-19 and influenced by gender, initial severity of dysfunction, emotional distress and depression, and SARS-CoV-2 variants. More studies are needed to illustrate their pathogenesis and to establish therapeutic strategies.
Keyphrases
- sars cov
- coronavirus disease
- respiratory syndrome coronavirus
- end stage renal disease
- depressive symptoms
- oxidative stress
- copy number
- ejection fraction
- chronic kidney disease
- gene expression
- risk factors
- dna methylation
- prognostic factors
- risk assessment
- sleep quality
- climate change
- genome wide
- smoking cessation
- virtual reality